Becton Dickinson (BDX) is back on investors’ radar after a reshuffle in Russell indices, with the stock added to the Russell ...

Becton Dickinson stock has fallen 22.8% year to date, yet the valuation checks and an intrinsic value estimate based on a ...

Don't sleep on these medical device leaders.

Waters Corporation (WAT) traded higher on Thursday after RBC Capital Markets launched its coverage with an Outperform rating and a $435 target, citing the U.S. life sciences company’s recent ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 6, 2026 to ...

BDX looks undervalued at 12–13x P/E with 7–8% growth, a 2.78% dividend, buybacks, and debt reduction. Click for more on BDX stock.

6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Shares of Becton Dickinson & Co. BDX slid 3.67% to $150.56 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.28% to 7,482.

Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company’s continued ...

Shares of Becton Dickinson & Co. BDX slid 1.61% to $155.54 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 7,537.43 ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...